Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,336,615
-$20,212,541 QoQ
Shares Held
180,092
-82.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#647
of 2,821 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names. PFE ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
This page
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in PFE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,336,615 | 180,092 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $24,549,156 | 1,012,754 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $41,900,804 | 1,653,544 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,264,948 | 273,839 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $342,852 | 11,847 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $991,247 | 35,427 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,098,066 | 75,606 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $36,892,398 | 1,281,431 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $53,721,037 | 1,619,567 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $65,495,147 | 1,785,582 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $68,340,734 | 1,675,018 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $140,222,769 | 2,736,588 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $124,211,534 | 2,838,472 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $158,216,700 | 3,017,675 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $171,568,627 | 3,314,055 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $43,264,222 | 732,671 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,109,682 | 165,303 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,317,487 | 161,325 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $271,217 | 7,486 | Shares | Sole | 2021-05-14 | |
| 2020-03-31 | $2,746,391 | 84,142 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||